A prospective, multicenter, open-label, single-arm clinical trial design to evaluate the safety and efficacy of 90Y resin microspheres for the treatment of unresectable HCC: the DOORwaY90 (Duration…

Overview of attention for article published in BMC Gastroenterology, March 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 113 followers.

Sharing the publication of the Doorway90 trial. Looking forward to the outcomes with personalized dosimetry for HCC @SirtexMedical @CheenuKappadath #Radioembolization. https://t.co/8cI0x2zSTa

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.